Using fractional exhaled nitric oxide to guide step-down treatment decisions in patients with asthma: a systematic review and individual patient data meta-analysis

Kay Wang, Jan Y. Verbakel, Jason Oke, Alexander Fleming-Nouri, Josh Brewin, Nia Roberts, Norihiro Harada, Ryo Atsuta, Kazuhisa Takahashi, Kazutaka Mori, Tomoyuki Fujisawa, Toshihiro Shirai, Tomotaka Kawayama, Hiromasa Inoue, Stephen Lazarus, Stanley Szefler, Fernando Martinez, Dominick Shaw, Ian D. Pavord, Mike Thomas

Source: Eur Respir J, 55 (5) 1902150; 10.1183/13993003.02150-2019
Journal Issue: May
Disease area: Airway diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Kay Wang, Jan Y. Verbakel, Jason Oke, Alexander Fleming-Nouri, Josh Brewin, Nia Roberts, Norihiro Harada, Ryo Atsuta, Kazuhisa Takahashi, Kazutaka Mori, Tomoyuki Fujisawa, Toshihiro Shirai, Tomotaka Kawayama, Hiromasa Inoue, Stephen Lazarus, Stanley Szefler, Fernando Martinez, Dominick Shaw, Ian D. Pavord, Mike Thomas. Using fractional exhaled nitric oxide to guide step-down treatment decisions in patients with asthma: a systematic review and individual patient data meta-analysis. Eur Respir J, 55 (5) 1902150; 10.1183/13993003.02150-2019

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Using fractional exhaled nitric oxide to guide step-down treatment decisions in asthma: practical considerations
Source: Eur Respir J, 56 (2) 2002809; 10.1183/13993003.02809-2020
Year: 2020



Fractional exhaled nitric oxide for the management of asthma in adults: a systematic review
Source: Eur Respir J 2016; 47: 751-768
Year: 2016



Predictive value of exhaled nitric oxide in the management of asthma: a systematic review
Source: Eur Respir J 2016; 48: 706-714
Year: 2016



Fractional exhaled nitric oxide in preterm-born subjects: A systematic review and meta-analysis.
Source: International Congress 2019 – Neonatal and paediatric intensive care
Year: 2019

The impact of fractional exhaled nitric oxide (FeNO) measurement on treatment decision making in the specialist care of established asthma
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013


Does treatment guided by exhaled nitric oxide fraction improve outcomes in subgroups of children with asthma?
Source: Eur Respir J, 55 (5) 1901879; 10.1183/13993003.01879-2019
Year: 2020



Exhaled nitric oxide (FeNO) levels to guide treatment for children with asthma: A Cochrane systematic review
Source: International Congress 2016 – Techniques and tools in paediatric asthma
Year: 2016


Exhaled nitric oxide (FeNO) levels to guide treatment for adults with asthma: A Cochrane systematic review
Source: International Congress 2016 – Inflammatory biomarkers in airway diseases
Year: 2016



Treatment decisions with an exhaled nitric oxide (eNO)-based algorithm vs a symptoms-based algorithm for asthma in pregnancy
Source: International Congress 2018 – Clinical determinants of asthma and biomarkers
Year: 2018




Inhaled nitric oxide (iNO) in a pediatric critical care unit. A retrospective review 1994–2006
Source: Annual Congress 2008 - Respiratory disorders in paediatric intensive care unit
Year: 2008


Opinions towards the implementation of spirometry and exhaled nitric oxide testing in children under investigation for asthma in primary care
Source: International Congress 2018 – Paediatric asthma: new mechanisms and tools
Year: 2018


Nasal nitric oxide screening for primary ciliary dyskinesia: systematic review and meta-analysis
Source: Eur Respir J 2014; 44: 1589-1599
Year: 2014




Assessing asthma control: questionnaires and exhaled nitric oxide provide complementary information
Source: Eur Respir J 2008; 32: 1419-1420
Year: 2008


An eye to the future: exhaled nitric oxide as a predictor of clinical outcomes in asthma
Source: Eur Respir J 2010; 35: 1200-1202
Year: 2010


The assessment of exhaled nitric oxide fraction in monitoring asthma control: How to raise the clinical relevance?
Source: Annual Congress 2010 - Cough, airway hyperresponsiveness and asthma control
Year: 2010


Exhaled NO in the long-term management of asthma a review of the evidence
Source: Annual Congress 2006 - "Inflammometry": an alternative strategy in the management of airways disease
Year: 2006


Improvement of asthma control assessed by exhaled nitric oxide: a real-life longitudinal study
Source: Eur Respir J 2005; 26: Suppl. 49, 276s
Year: 2005

The cost and benefits of exhaled nitric oxide (NO) measurement in asthma - The results from three years follow-up study
Source: International Congress 2018 – Determinants and monitoring of asthma control
Year: 2018




Inhaled corticosteroids in asthma and longitudinal change in lung function: a systematic review and meta-analysis
Source: International Congress 2019 – Asthma treatment: cohorts and real-world studies
Year: 2019


Fractional exhaled nitric oxide (FeNO) suppression with directly observed inhaled corticosteroid therapy: does it make a difference to patient outcomes?
Source: International Congress 2018 – Clinical and functional monitoring in airway disease
Year: 2018